infliximab-dyyb
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Infliximab biosimilar (CT-P13/infliximab-dyyb; Remsima®, Inflectra®) is approved in several countries for use in all indications…